Unlock instant, AI-driven research and patent intelligence for your innovation.

Salt of quinoline compound as well as preparation method and application of salt

A compound and composition technology, applied in the field of quinoline compound salt and its preparation

Active Publication Date: 2022-04-05
NANJING ZHENGXIANG PHARMA CO LTD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] Although a number of PI3Kδ inhibitors are already on the market or under research, there is still a huge demand for PI3Kδ inhibitors with better clinical efficacy and less toxic side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Salt of quinoline compound as well as preparation method and application of salt
  • Salt of quinoline compound as well as preparation method and application of salt
  • Salt of quinoline compound as well as preparation method and application of salt

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0086] Example 1 Compound A was prepared by using known compound 1 and compound 4. Among them, compound 1 and compound 4 can be obtained commercially, or can be synthesized by referring to known routes, for example, compound 1 and compound 4 can be obtained by referring to the contents recorded in the Chinese patent application number 201780004233.0.

[0087]

[0088] Step 1: In N 2 i-PrMgCl (13 L) and tetrahydrofuran (THF, 4.0 L) were added to the reaction vessel under atmosphere. Then a solution of 2-bromopyridine (4.12 kg) in THF (4.0 L) was added at 30±5°C. The mixture was stirred at 30±5°C for at least 2 hours. Then add ZnBr 2 (7.05kg) in THF (10L), and the reaction system was stirred at 30±10°C for at least 1 hour. Compound 1 (4.3kg), XPhos (748g), NaI (198g) and Pd(AcO) 2 (89 g) was added to the reaction vessel, the resulting mixture was heated to 65±5°C, and the reaction was stirred at 65±5°C for at least 24 hours. Then cool to 25±5°C. Dichloromethane (DCM, 20 ...

Embodiment 2

[0092] Embodiment 2 uses 12 kinds of acids to carry out 96-orifice plate salt-forming screening to compound A prepared in Example 1, and the solid sample prepared in the salt-forming screening is passed nuclear magnetic ( 1 H NMR) and X-ray powder diffraction (XRPD) were used to confirm the analysis.

[0093] in 1 The instrument used for H NMR analysis is a Bruker Advance 300 equipped with a B-ACS 120 automatic sampling system.

[0094] The X-ray diffraction analyzer used in the XRPD used in this embodiment and elsewhere in this specification is BrukerD8advance, which is equipped with a LynxEye detector. The 2θ scanning angle of the sample is from 3° to 40°, and the scanning step is 0.02°. The test sample light tube voltage and current were 40KV and 40mA.

[0095] Wherein, an appropriate amount of Compound A was dissolved in methanol to prepare a drug solution with a concentration of 30 mg / mL.

[0096] The acids used in the experiments are shown in Table 1 below. A certain ...

Embodiment 3

[0111] Example 3 Based on the results of salt formation screening on a 96-well plate, various salts were prepared. The experiment was carried out by adding a certain amount of solvent to an appropriate amount of free base, and then adding acid at room temperature or under heating conditions to conduct a salt formation experiment.

[0112] 1. p-toluenesulfonate

[0113] As shown in Table 4, p-toluenesulfonate salts were prepared in different solvents at room temperature or at 40°C, and the sample numbers of the obtained p-toluenesulfonate salts were listed in the first column of Table 4, respectively. Figure 5 It shows that the sample 1, sample 2, sample 3 and sample 4 prepared in different solvents and the 96-well plate-G4 sample prepared in the above example 2 have basically the same XRPD patterns, which are named p-toluenesulfonate crystal form I.

[0114] Table 4 Preparation of p-toluenesulfonate

[0115]

[0116]

[0117] Then take sample 3 as an example to carry ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Mean tumor volumeaaaaaaaaaa
Mean tumor volumeaaaaaaaaaa
Login to View More

Abstract

The invention relates to the field of biological medicine, and provides a salt of a quinoline compound, and a preparation method and application thereof. The quinoline compound is shown as a formula (I), and the provided salt can be used as an inhibitor of phosphoinositide 3-kinase and is used for treating phosphoinositide 3-kinase related diseases.

Description

technical field [0001] The invention relates to the field of biomedicine, in particular to a salt of a quinoline compound, a preparation method and application thereof. Background technique [0002] Phosphoinositide 3-kinases (PI3Ks) belong to a large family of lipid signaling kinases. Among them, class I PI3Ks (including PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ) belong to the family of dual-specificity lipid and protein kinases, and PI3K itself has serine / threonine (Ser / Thr) kinase activity, which can phosphorylate phosphatidylinositol 4,5-diphosphate (PIP 2 ), resulting in phosphatidylinositol-3,4-,5-triphosphate (PIP 3 ). PIP 3 Plays a key role in cell survival, signal transduction, control of transmembrane transport and other functions, and participates in the regulation of various cellular functions such as cell proliferation, differentiation, apoptosis and glucose transport (Di Paolo, G. et al. Nature, 2006 ,443,651; Parker,P.J.et al.Biochem.Soc.Trans.2004,32,893;Hawkins,P....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D401/04C07D401/14C07C303/32C07C309/04C07C309/30A61P35/00A61K31/506
Inventor 郝小林
Owner NANJING ZHENGXIANG PHARMA CO LTD
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More